International safety notice
The influence of low-molecular-weight heparin (LMWH) on DNA in the blood plasma of pregnant women, LifeCodexx AG,
Germany / BfArM · DEU · May 28, 2015
Key facts
| Title | The influence of low-molecular-weight heparin (LMWH) on DNA in the blood plasma of pregnant women, LifeCodexx AG, |
|---|---|
| Regulator | Germany / BfArM |
| Country | DEU |
| Brand | The influence of low-molecular-weight heparin (LMWH) on DNA in the blood plasma of pregnant women, LifeCodexx AG, |
| Manufacturer | The influence of low-molecular-weight heparin (LMWH) on DNA in the blood plasma of pregnant women, LifeCodexx AG, |
| Date | May 28, 2015 |
| Regulator page | bfarm.deSharedDocs |
At a glance
- No Recall
- No Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1